Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (21-30 of 372) with videos related to

Pageof 38
Sort By:
Lancet (London, England)|September 21, 2002
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanKenneth Dickstein, John Kjekshus,
European Journal of Cardiovascular Nursing|August 5, 2006
The challenge of implementing heart failure management programmes throughout EuropeKenneth Dickstein, Tiny Jaarsma
European Heart Journal|October 3, 2003
Neurohormonal inhibition in heart failure, is there no limit?Stein Ørn, Kenneth Dickstein
European Journal of Heart Failure|July 4, 2015
Predicting outcomes following CRT: the quest continuesCamilla Normand, Kenneth Dickstein
European Journal of Heart Failure|February 19, 2005
Heart failure management programmes: delivering the messageKenneth Dickstein, Tiny Jaarsma
European Journal of Cardiovascular Nursing|November 18, 2008
What is new and of special interest to nurses in the 2008 ESC guidelines for diagnosis and treatment of acute and chronic heart failure?Anna Strömberg, Kenneth Dickstein
European Journal of Heart Failure|July 15, 2016
Does the presence of mitral regurgitation strengthen or weaken the indication for cardiac resynchronization therapy?Camilla Normand, Kenneth Dickstein
European Heart Journal|February 19, 2016
Heart failure in the Middle East An Emerging Challenge in a Diverse EnvironmentHadi Skouri, Kenneth Dickstein
European Journal of Heart Failure|February 13, 2018
Guideline recommendations for cardiac resynchronization therapy evolve but does clinical practice match the pace?Camilla Normand, Kenneth Dickstein
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trialVernon VS Bonarjee, Kenneth Dickstein
Pageof 38

Showing results (21-30 of 372) with videos related to

Sort By:
Pageof 38
Lancet (London, England)|September 21, 2002
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanKenneth Dickstein, John Kjekshus,
European Journal of Cardiovascular Nursing|August 5, 2006
The challenge of implementing heart failure management programmes throughout EuropeKenneth Dickstein, Tiny Jaarsma
European Heart Journal|October 3, 2003
Neurohormonal inhibition in heart failure, is there no limit?Stein Ørn, Kenneth Dickstein
European Journal of Heart Failure|July 4, 2015
Predicting outcomes following CRT: the quest continuesCamilla Normand, Kenneth Dickstein
European Journal of Heart Failure|February 19, 2005
Heart failure management programmes: delivering the messageKenneth Dickstein, Tiny Jaarsma
European Journal of Cardiovascular Nursing|November 18, 2008
What is new and of special interest to nurses in the 2008 ESC guidelines for diagnosis and treatment of acute and chronic heart failure?Anna Strömberg, Kenneth Dickstein
European Journal of Heart Failure|July 15, 2016
Does the presence of mitral regurgitation strengthen or weaken the indication for cardiac resynchronization therapy?Camilla Normand, Kenneth Dickstein
European Heart Journal|February 19, 2016
Heart failure in the Middle East An Emerging Challenge in a Diverse EnvironmentHadi Skouri, Kenneth Dickstein
European Journal of Heart Failure|February 13, 2018
Guideline recommendations for cardiac resynchronization therapy evolve but does clinical practice match the pace?Camilla Normand, Kenneth Dickstein
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trialVernon VS Bonarjee, Kenneth Dickstein
Pageof 38